At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
Our UHN programs and services are among the most advanced in the world. We have grouped our physicians,
staff, services and resources into 10 medical programs to meet the needs of our patients and help us make
the most of our resources.
At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
University Health Network is a health care and medical research organization in
Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international
source for discovery, education and patient care.
Being touched by illness affects us in different ways. Many people want to give back to the community
and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one
of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases,
podcasts and more.
Toronto (Aug. 12, 2015) – New research from Toronto Western Hospital's Spodyloarthritis Program reveals people with a type of spinal arthritis called ankylosing spondylitis (AS) have a higher risk of dying from a heart attack or stroke than the general population. The study, "Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study," published online in the Annals of Internal Medicine links AS with a 35 per cent higher risk of dying from heart attack and a 60 percent increase risk of dying from stroke than those without AS.
Drs. Nigil Haroon and Nisha Haroon, a husband and wife team, designed a population-based study including over 21,000 AS patients and 86,000 controls without AS, to determine the level of mortality risk AS patients face.
"This research provides a bigger picture as to what patients with AS might face living with this disease," says Dr. Nigil Haroon, lead researcher and specialist in spondyloarthritis. "The study shows that it is important that patients receive comprehensive screening, preventative care, as well as optimal management of cardiovascular and cerebrovascular disease."
This increased risk is particularly significant considering AS typically starts at a relatively young age, between the ages of 20 and 40, much earlier than other forms of arthritis like rheumatoid arthritis.
AS is a type of inflammatory arthritis. Apart from inflammation, new bone formation is a major feature of AS. As a result, the bones of the spine begin to fuse together causing the spine to become very stiff and inflexible. While there is no cure for AS, drug treatments known as biologics (engineered proteins derived from cells) have been shown to reduce symptoms and halt the progression of the disease. Dr. Haroon led an international research study of 335 patients published in the leading rheumatology journal Arthritis and Rheumatism, that showed at least 50 per cent reduction in the risk of progression of AS with the use of TNF inhibitors, type of biologic therapy.
"Another additional factor to consider is that male AS patients have 82 per cent higher risk of vascular mortality compared to females with AS," said Dr. Nigil Haroon. "This further underscores the importance of understanding all of the additional health risks associated with AS and the need for more research to fully understand the connection between chronic inflammation and heart disease and stroke."
Toronto Western Hospital has been serving the health care needs of its culturally diverse local community for more than 100 years. Home to the Krembil Neuroscience Centre, one of the largest combined clinical and research neurological facilities in North America, the Toronto Western Hospital is a leader in medical research and also offers expertise in community and population health and musculoskeletal health and arthritis. The Toronto Western Hospital, along with the Princess Margaret Cancer Centre, Toronto General Hospital and Toronto Rehabilitation Institute, is a member of the University Health Network and is affiliated with the University of Toronto.
Phone: 416 340 4636